The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVV.L Regulatory News (AVV)

  • There is currently no data for AVV

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Clearances and timetable to closing update

12 Feb 2018 07:00

RNS Number : 5172E
AVEVA Group PLC
12 February 2018
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE AND IN PART, DIRECTLY OR INDIRECTLY IN OR INTO AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

 

THE FOLLOWING ANNOUNCEMENT IS AN ADVERTISEMENT AND NOT A PROSPECTUS AND INVESTORS SHOULD NOT MAKE ANY INVESTMENT DECISION IN RELATION TO AVEVA SHARES EXCEPT ON THE BASIS OF THE INFORMATION IN THE AVEVA CIRCULAR AND PROSPECTUS DATED 5 SEPTEMBER 2017 WHICH IS AVAILABLE AT WWW.AVEVA.COM

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

12 February 2018

 

AVEVA GROUP PLC

 

Combination of AVEVA and the Schneider Electric industrial software business: update re clearances and timetable to closing

 

AVEVA Group plc ("AVEVA" or "the Group"), one of the world's leading providers of engineering data and design IT systems, is pleased to announce that the review by the Committee on Foreign Investments in the United States ("CFIUS") has now concluded and clearance has now been received for the proposed Combination of AVEVA and the Schneider Electric industrial software business.

 

As a result, all conditions for Completion of the Combination have been fulfilled, save for Admission, which is expected on 1 March 2018. The record date for the £650 million cash Return of Value to AVEVA shareholders is expected to be 6.00 p.m. (London time) on 28 February 2018. The Return of Value is expected to be in an amount of 1,015 pence per Ordinary Share and will be effected by way of a B Share Scheme. B Shares would be issued and redeemed as soon as reasonably practicable on the day of Completion. From 7 days following this there would be a despatch of cheques or, if Ordinary Shares are held in CREST, CREST accounts would be credited in respect of proceeds of redemption. In the circumstances described in the Prospectus dated 5 September 2017, the Return of Value may be effected in a different manner, in which event a further announcement will be made.

 

As previously communicated, contrary to AVEVA's expectations based on tax advice received at the time, Her Majesty's Revenue and Customs ("HMRC") has to date taken the view that the issue of B shares paid up from AVEVA's merger reserve to effect the £650 million Return of Value as part of the Combination should be treated as a distribution and therefore taxed as income in the hands of recipients for UK tax purposes. AVEVA's advisers have had further correspondence with HMRC in relation to the expected tax treatment of the Return of Value, but AVEVA understands that a substantive response from HMRC is unlikely to be received before the expected Record Date for the Return of Value. Shareholders may wish to seek their own tax advice in this regard and are reminded to consider the guidance in Part XI of the Prospectus.

 

Defined terms used in this announcement shall have the meaning given to them in the Prospectus published by the Company on 5 September 2017 (the "Prospectus").

 

 

Enquiries:

 

AVEVA Group plc

Matt Springett, Head of Investor Relations

Tel: 01223 556 676

 

Lead Financial Adviser to AVEVA

Lazard

 

Cyrus Kapadia

Richard Hoyle

Philippe Noël

Tel: +44 (0) 20 7187 2000

 

 

Corporate Broker, Sponsor and Financial Adviser to AVEVA

Numis

 

Simon Willis

Jamie Lillywhite

Jamie Loughborough

Tel: +44 (0) 20 7260 1000

 

FTI Consulting LLP

Edward Bridges / Dwight Burden

Tel: 020 3727 1000

 

 

Other

 

The information contained within this announcement is inside information as stipulated under the MAR. Upon the publication of this announcement this inside information is now considered to be in the public domain. The person responsible for this announcement on behalf of AVEVA is David Ward, Chief Financial Officer.

 

LEI: 213800XHATUM2LFMKG16

Classification: 2.2 (Inside Information)

 

IMPORTANT NOTICES:

 

Lazard & Co., Limited ("Lazard"), which is authorised and regulated in the UK by the Financial Conduct Authority, is acting as lead financial adviser to AVEVA and no one else in connection with the Combination and will not be responsible to anyone other than AVEVA for providing the protections afforded to clients of Lazard & Co., Limited nor for providing advice in relation to the Combination or any other matters referred to in this announcement. Neither Lazard & Co., Limited nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Lazard & Co., Limited in connection with this announcement, or any the Combination or any statement contained herein.

 

Numis Securities Limited ("Numis"), which is authorised and regulated in the UK by the Financial Conduct Authority, is acting as corporate broker, sponsor and financial adviser to AVEVA and no one else in connection with the Combination and will not be responsible to anyone other than AVEVA for providing the protections afforded to clients of Numis nor for providing advice in relation to the Combination or any other matters referred to in this announcement. Neither Numis nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Numis, in connection with this announcement, or the Combination or statement contained herein.

 

No person has been authorised to give any information or to make any representations other than those contained in this announcement and, if given or made, such information or representations must not be relied on as having been authorised by AVEVA, Lazard and/or Numis. Subject to the Listing Rules, the Prospectus Rules and the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, the issue of this announcement shall not, in any circumstances, create any implication that there has been no change in the affairs of the AVEVA Group or Schneider Electric since the date of this announcement or that the information in it is correct as at any subsequent date.

 

This announcement does not constitute or form part of any offer, invitation to sell, otherwise dispose of or issue, or any solicitation of any offer to purchase or subscribe for, any shares or other securities nor shall it or any part of it, nor the fact of its distribution form the basis of, or be relied on in connection with, any contract commitment or investment decision.

 

This announcement has been prepared for the purpose of complying with the applicable law and regulation of the United Kingdom and information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of jurisdictions outside the United Kingdom.

 

The distribution of this announcement in jurisdictions other than the United Kingdom may be affected by the laws of relevant jurisdictions. Therefore any persons who are subject to the laws of any jurisdiction other than the United Kingdom will need to inform themselves about, and observe any, applicable requirements.

 

This announcement does not constitute an offer of securities for sale in the United States or an offer to acquire or exchange securities in the United States. No offer to acquire securities or to exchange securities for other securities has been made, or will be made, directly or indirectly, in or into, or by use of the mails, any means or instrumentality of interstate or foreign commerce or any facilities of a national securities exchange of, the United States or any other country in which such offer may not be made other than (i) in accordance with the tender offer requirements under the US Securities Exchange Act of 1934, as amended, or the securities laws of such other country, as the case may be, or (ii) pursuant to an available exemption from such requirements.

 

Neither the content of AVEVA nor Schneider Electric website, nor any website accessible by hyperlinks on AVEVA or Schneider Electric website is incorporated in, or forms part of, this announcement.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMMGMZKMVGRZM
Date   Source Headline
18th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc
18th Jan 20232:27 pmRNSForm 8.3 - AVEVA Group plc
18th Jan 20231:59 pmRNSForm 8.3 - AVEVA GROUP PLC
18th Jan 20231:11 pmEQSForm 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
18th Jan 202312:02 pmRNSForm 8.5 (EPT/NON-RI)-AVEVA Group plc Amend
18th Jan 202311:11 amRNSForm 8.5 (EPT/RI) - Aveva Group Plc
18th Jan 202311:00 amRNSSCHEME OF ARRANGEMENT BECOMES EFFECTIVE
18th Jan 20239:58 amRNSForm 8.5 (EPT/NON-RI)-AVEVA Group plc
18th Jan 20239:52 amRNSForm 8.3 - Aveva Group Plc
18th Jan 20239:52 amRNSForm 8.5 (EPT/RI)-AVEVA Group plc
18th Jan 20239:10 amRNSForm 8.5 (EPT/RI)
18th Jan 20237:30 amRNSSuspension- Aveva Group PLC
17th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc
17th Jan 20231:23 pmRNSForm 8.3 - AVEVA GROUP PLC
17th Jan 20231:04 pmRNSForm 8.3 - Aveva Group PLC
17th Jan 202312:28 pmRNSForm 8.3 -AVEVA GROUP PLC
17th Jan 202310:38 amRNSForm 8.5 (EPT/RI) - Aveva Group Plc
17th Jan 202310:33 amRNSISSUE AND ALLOTMENT OF NEW AVEVA SHARES
17th Jan 202310:22 amRNSForm 8.3 - Aveva Group Plc
17th Jan 202310:19 amRNSForm 8.5 (EPT/NON-RI)-AVEVA Group plc
17th Jan 202310:10 amRNSForm 8.5 (EPT/RI)-AVEVA Group plc
16th Jan 20233:28 pmRNSCOURT SANCTION OF SCHEME
16th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc
16th Jan 20231:30 pmEQSForm 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
16th Jan 202311:24 amRNSForm 8.5 (EPT/RI) - Aveva Group Plc
16th Jan 202311:17 amRNSForm 8.3 - AVEVA GROUP PLC
16th Jan 202311:14 amRNSForm 8.3 - Aveva Group Plc
16th Jan 202310:12 amRNSForm 8.5 (EPT/NON-RI)-AVEVA Group plc
16th Jan 202310:05 amRNSForm 8.5 (EPT/RI)-AVEVA Group plc
16th Jan 20238:53 amRNSForm 8.5 (EPT/RI)
13th Jan 20236:12 pmRNSAveva Group
13th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc
13th Jan 20231:33 pmEQSForm 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
13th Jan 202311:20 amRNSForm 8.3 - AVEVA GROUP PLC
13th Jan 202310:26 amRNSForm 8.5 (EPT/RI) - Aveva Group Plc
13th Jan 202310:18 amRNSForm 8.5 (EPT/NON-RI)-AVEVA Group plc
13th Jan 202310:15 amRNSForm 8.5 (EPT/RI)-AVEVA Group plc
13th Jan 20239:01 amRNSForm 8.5 (EPT/RI)
13th Jan 20237:00 amRNSForm 8.3 - AVEVA GROUP PLC Amend
12th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc
12th Jan 20233:06 pmRNSForm 8.3 - AVEVA Group plc
12th Jan 20231:24 pmEQSForm 8.3 - The Vanguard Group, Inc.: AVEVA Group plc
12th Jan 202312:05 pmRNSForm 8.3 - AVEVA GROUP PLC
12th Jan 202311:23 amRNSForm 8.5 (EPT/RI) Aveva Group Plc
12th Jan 202310:28 amBUSForm 8.3 - AVV LN Equity 11-January-23 Decrease in Traded Position Disclosure
12th Jan 202310:23 amRNSForm 8.5 (EPT/NON-RI) - AVEVA Group plc
12th Jan 202310:17 amRNSForm 8.5 (EPT/RI) - AVEVA Group plc
12th Jan 20238:35 amRNSForm 8.5 (EPT/RI)
11th Jan 20236:00 pmRNSAveva Group
11th Jan 20233:20 pmRNSForm 8.3 - AVEVA Group plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.